LNTH
Lantheus Holdings Inc
Halal Rating :
Last Price
$91.43
Last updated:
Market Cap
-
7D Change
-3.4%
1 Year Change
66.63%
Company Overview
Industries
Exchange
Next Earnings Date
Lantheus Holdings, Inc. is a radiopharmaceutical company that develops, manufactures, and commercializes diagnostic and therapeutic products. The company focuses on precision diagnostics and targeted therapeutics that enable clinicians to identify and treat diseases with greater accuracy. Their main products include diagnostic imaging agents and radiotherapeutics used primarily in the diagnosis and treatment of cardiovascular and oncological diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $378.73m | $249.89m | - | $4.9m | 0.00% | 1.96% |
| June 30, 2024 | $394.09m | $296.22m | - | $4.86m | 0.00% | 1.64% |
| March 31, 2024 | $369.98m | $268.2m | - | $4.86m | 0.00% | 1.81% |
Company Impact
Help us evaluate Lantheus Holdings Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.